Sanofi and Regeneron's checkpoint inhibitor Libtayo has tripled its approved uses in Europe, after getting the nod for the treatment of advanced basal cell carcinoma (BCC) and advanced non-small ...

The EC approval also now means that Libtayo can be used to treat certain patients across four types of cancer within the European Union: advanced squamous cell carcinoma (SCC), advanced basal cell ...

Cell biology is the discipline of biological ... to engineer bispecific chimeric TCRs that may be more effective at treating cancer than traditional chimeric antigen receptor T cells.

Your professional path has been a work in progress since spring 2023, and Saturday can clarify the next steps you need to take. An Aries solar (new moon) eclipse—the final one in a three-part ...

A cell therapy is a medicinal product containing cells, and is typically injected into a patient. Examples include bone marrow transplants (also known as haematopoietic stem cell transplantation ...

Mar. 26, 2025 — Researchers have developed 'tomoseqr' -- a new software tool that enables easy estimation of the three-dimensional (3D) spatial distribution of gene expression. Tomoseqr is free ...

Methods: 367 patients with primary breast cancer were recruited from April 2004 to December 2010 at 1st Department of Surgery, Sapporo Medical University. ER, PgR, and HER2 status were evaluated in ...

According to the American Cancer Society, those with stage 4 non-small cell lung cancer (NSCLC) diagnosed between 2012 and 2018 had a five-year relative survival rate of 9%. However, that doesn't tell ...

Researchers focused on a pathway that harnesses reactive oxygen species (ROS) to kill cancer cells. The study ...

Chronic lymphocytic leukemia (CLL) is a type of cancer that starts in white blood cells (called lymphocytes) in the bone marrow. CLL mainly affects older adults and accounts for about one-third of all ...